The decline in AAMRs is consistent with improvements in hypertension control, pharmacologic interventions (e.g., ACE inhibitors, beta-blockers), and increased awareness of cardiovascular risk factors [13]. The gene discussed is ACE; the disease is hypertensive disorder.